You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《業績》英國藥廠GSK次季盈利勝預期 上調疫苗板塊全年收入預測
阿思達克 07-30 14:59
英國藥廠葛蘭素史克(GSK)公布次季業績,銷售79.86億英鎊,按年升1%,以固定匯率計升6%。撇除特定項目,次季核心每股盈利46.5便士,勝市場預期的42.4便士。 GSK上調兩大核心板塊今年收入預測,包括疫苗,料按年持平,原先料按年下跌。公司指,今年銷售料處於指引範圍(3%至5%)的高端;核心經營溢利全年料升6%至8%,核心每股盈利料升6%至8%。集團計劃今年底前就四項藥品展開後期臨床,包括兩款癌症藥,一項脂肪肝療程及超長效HIV藥物。(da/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account